Tatva Chintan Pharma Chem Ltd Share Price

Chemicals - Speciality - Medium / Small

NSE: TATVA Small Cap ISIN: INE0GK401011

As on 22 January 2025 at 18:13 IST

₹825.45

-18.10

(-2.15%)

Sell Buy

Over 1 Month

3.76%

Over 6 Months

-21.62%

Over 1 Year

-38.45%

Over 3 Years

-67.63%

Tatva Chintan Pharma Chem Ltd Summary

Close ₹ 825.45

Open ₹ 840.05

High ₹ 855.90

Low ₹ 812

Volume 19,125

Net Turnover (in ₹) ₹ 86,24,170.60

52Wk High ₹ 1,419.80

52Wk Low ₹ 788.50

52Wk High / Low

788.50

1,419.80

Tatva Chintan Pharma Chem Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 1,973.24

EPS (TTM) 5.68

Book Value (BV) 308.43

Div. Yield 0.24 %

P/E (TTM) 148.53

Price/Book Value 2.74

Delivery % 50.62 %

Face Value 10

Key Ratios

PE Ratio 86.02

PB Ratio 3.48

EV to Sales 6.61

PEG Ratio -2.75

ROA 3.96

ROE 4.77

Debt-Equity 0.15

Net Profit Margin 7.75

Operating Profit Margin 19.68

Tatva Chintan Pharma Chem Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	401.01	429.36	442.54	305.56	264.62
Total Expenses	357.44	380.99	338.42	244.86	217.03
Profit Before Tax	43.57	44.78	104.12	60.70	47.60
Profit After Tax	30.35	45.49	95.87	52.26	37.79
Operating Profit after Depreciation	50.10	56.77	108.95	64.90	51.54

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	430.50	196.25	159.61	120.45	111.18
Total Non Current Assets	520.81	446.61	222.42	130.55	116.24
Total Current Assets	297.91	312.25	435.88	184.25	132.70
TOTAL ASSETS	818.72	758.86	658.30	314.80	248.94
Total Shareholder's Fund	737.08	514.79	473.09	165.96	117.69

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	98.04	27.78	20.38	19.69	25.31
Net Cash used in Investing Activities	-120.62	-101.23	-196.81	-20.66	-40.18
Net Cash used in Financing Activities	30.52	37.80	234.96	-4.71	9.95

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	386.19	408.72	438.44	296.29	254.40
Total Expenses	343.92	366.30	335.17	236.94	210.18
Profit Before Tax	42.27	38.83	103.27	59.35	44.22
Profit After Tax	29.35	40.47	95.99	51.36	34.96
Operating Profit after Depreciation	48.77	50.80	108.22	63.55	48.16

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	430.48	196.22	159.61	120.45	111.18
Total Non Current Assets	521.46	447.25	223.08	131.22	116.90
Total Current Assets	293.61	307.61	453.12	178.46	128.40
TOTAL ASSETS	815.07	754.86	676.20	309.68	245.31
Total Shareholder's Fund	725.88	504.78	468.88	161.94	114.45

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	102.78	23.73	19.76	18.91	24.64
Net Cash used in Investing Activities	-120.52	-101.13	-196.72	-20.61	-40.18
Net Cash used in Financing Activities	30.54	37.82	235.01	-4.72	9.70

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	83.49	105.46	98.27	84.21	96.67
Total Expenses	77.91	92.84	82.66	73.22	76.42
Profit Before Tax	-1.02	6.81	13.70	5.24	11.22
Profit After Tax	-0.66	5.21	9.61	3.46	7.78
Operating Profit after Depreciation	5.96	13.79	20.14	12.20	21.01

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	80.96	93.81	93.93	86.07	92.57
Total Expenses	76.36	86.12	79.73	73.76	71.83
Profit Before Tax	-1.57	2.14	12.28	6.56	11.71
Profit After Tax	-1.11	1.51	8.25	4.65	8.20
Operating Profit after Depreciation	5.41	9.11	18.73	13.52	21.50

Tatva Chintan Pharma Chem Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 828.30

S2 813.05

S3 790.10

Pivot 851.25

R1 866.50

R2 889.45

R3 904.70

Moving Average

20 SMA 860.92

50 SMA 864.03

100 SMA 914.62

200 SMA 1,008.86

Tatva Chintan Pharma Chem Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

Tatva Chintan Pharma Chem Ltd

₹2/Share

Announcement Date 06 Sep 2024

Record Date 07 Sep 2024

Div Yield 20%

AGM Date: 22 Sep 2022

AGM 22/09/2022 Pursuant to Regulation 30 of the SEBI Listing Regulations, please find enclosed herewith Notice of the 26th AGM of the Members of the Company scheduled to be held on Thursday, 22 September 2022 at 04:00 p.m. (IST) through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM'). The Notice of the 26th AGM of the Company is also available on the website of the Company at www.tatvachintan.com. Kindly take the above information on record. (As Per BSE Announcement Dated on 23.08.2022) Pursuant to provisions of Regulation 30 read with Part A of Schedule III and all other applicable regulations, if any, of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, please find enclosed herewith Proceedings of the 26th Annual General Meeting ('AGM') of the Members of Tatva Chintan Pharma Chem Limited ('the Company') held on Thursday, 22 September 2022 at 04:00 p.m. (IST), through Video Conferencing ('VC') / Other Audio-Visual Means ('OAVM'). The proceedings of 26th Annual General Meeting of the Company shall be made available on the website of the Company at www.tatvachintan.com. (As Per BSE Announcement Dated on 22.09.2022) Pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, please find enclosed the voting results of the business transacted at the 26th Annual General Meeting ('AGM') of the members of the Company held on Thursday, 22 September 2022 at 04:00 p.m. (IST) through Video Conference ('VC') / Other Audio Visual Means ('OAVM'). We are also enclosing herewith the Consolidated Report of the Scrutinizer on the remote e-voting and e-voting held during the course of AGM. The above are also being uploaded at the Company''s website at www.tatvachintan.com and on the website of Link Intime India Private Limited, an agency appointed for the purpose of conducting the remote e-voting and e-voting during the process of AGM. (As per BSE Announcement Dated on 23/9/2022)

AGM Date: 22 Sep 2023

Newspaper Advertisement - Disclosure under Regulation 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. ('SEBI Listing Regulations') Newspaper Advertisement - Disclosure under Regulation 30, 44 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. ('SEBI Listing Regulations') (As Per BSE Announcement dated on 27.08.2023) Summary of proceedings of the 27th Annual General Meeting held on Friday, 22 September 2023 (As Per BSE Announcement dated on 22.09.2023) Scrutinizer''s Report / Voting Results of 27th Annual General Meeting of the Company held on Friday, 22 September 2023 (As Per BSE Announcement Dated on 23/09/2023)

AGM Date: 20 Sep 2024

AGM 20/09/2024 Summary of proceedings of the 28th Annual General Meeting held on Friday, 20 September 2024 (As Per BSE Announcement Dated on: 20/09/2024) Scrutinizer''s Report / Voting Results of 28th Annual General Meeting of the Company held on Friday, 20 September 2024 (As Per BSE Announcement dated on 21.09.2024)

Tatva Chintan Pharma Chem Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Tatva Chintan Pharma Chem Ltd	₹843.65	₹1,973.47
Pidilite Industries Ltd	₹2,749	₹1,39,826.80
SRF Ltd	₹2,574.35	₹76,310.12
Linde India Ltd	₹5,841.85	₹49,819.30
Gujarat Fluorochemicals Ltd	₹3,783.70	₹41,563.94
Deepak Nitrite Ltd	₹2,347.70	₹32,020.99

Tatva Chintan Pharma Chem Ltd News

Tatva Chintan Pharma Chem declare Quarterly Result

On 28 January 2025

17 Jan 2025, 05:27 pm

Tatva Chintan Pharma Chem to discuss results

On 25 October 2024

17 Oct 2024, 04:28 pm

Tatva Chintan Pharma Chem AGM scheduled

On 20 September 2024

28 Aug 2024, 02:54 pm

Tatva Chintan Pharma Chem to convene board meeting

On 24 July 2024

16 Jul 2024, 03:55 pm

Tatva Chintan Pharma Q4 PAT drops 43% YoY to Rs 96 cr

Tatva Chintan Pharma Chem reported 43.30% decline in consolidated net profit to Rs 96.14 crore in Q4 FY24 as compared with Rs 169.54 crore posted in Q4 FY23.

04 May 2024, 01:28 pm

Tatva Chintan Pharma Chem Ltd Stock Analysis

Annual revenue for Tatva Chintan Pharma Chem Ltd decreased by 5.51% to ₹386.19 crore in FY 2024 from ₹408.72 crore in FY 2023.
Annual Net Profit for Tatva Chintan Pharma Chem Ltd decreased by 27.47% to ₹29.35 crore in FY 2024 from ₹40.47 crore in FY 2023.
Promoter Shareholding in Tatva Chintan Pharma Chem Ltd remains unchanged by 0.00% in the most recent quarter, from 72.02% in September 2024 to 72.02% in December 2024.
Tatva Chintan Pharma Chem Ltd delivered a 1-year return of -38.45% compared to the Nifty 50, which provided a return of 8.41% as of the last trading session.
Tatva Chintan Pharma Chem Ltd share price moved down by 2.15% from its previous close of INR ₹843.55. The latest Tatva Chintan Pharma Chem Ltd share price is INR ₹825.45.
Tatva Chintan Pharma Chem Ltd share price today has been at a low of 812 and a high of 855.90. Over the past 52 weeks, the Tatva Chintan Pharma Chem Ltd share price has seen a low of 788.50 and a high of 1,419.80.